Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation

Journal of Immunology

Volumn 190, Issue 5, 2013, Pages 2292-2300

  Osborne, Lisa C ^a   Joyce, Karen L ^a   Alenghat, Theresa ^a   Sonnenberg, Gregory F ^a   Giacomin, Paul R ^a,d   Du, Yurong ^a   Bergstrom, Kirk S ^b,e   Vallance, Bruce A ^b   Nair, Meera G ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JAMES COOK UNIVERSITY   (Australia)

^e OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23P19; RESISTIN; RESISTIN LIKE MOLECULE ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CITROBACTER RODENTIUM; COLITIS; CONTROLLED STUDY; EOSINOPHIL; EPITHELIUM CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL;

ADAPTIVE IMMUNITY; ANIMALS; CITROBACTER RODENTIUM; DEXTRAN SULFATE; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-17; INTERLEUKIN-23 SUBUNIT P19; INTESTINES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS; TH17 CELLS;

EID: 84874233747     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200706     Document Type: Article

References (36)

1. Holcomb, I. N., R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, C. Nelson, H. B. Lowman, B. D. Wright, N. J. Skelton, et al. 2000. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19: 4046-4055.
2. Munitz, A., L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg. 2009. Resistin-like molecule a decreases glucose tolerance during intestinal inflammation. J. Immunol. 182: 2357-2363.
3. Munitz, A., A. Waddell, L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg. 2008. Resistin-like molecule a enhances myeloid cell activation and promotes colitis. J. Allergy Clin. Immunol. 122: 1200-1207, e1.
4. Loke, P., M. G. Nair, J. Parkinson, D. Guiliano, M. Blaxter, and J. E. Allen. 2002. IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 3: 7.
5. Nair, M. G., I. J. Gallagher, M. D. Taylor, P. Loke, P. S. Coulson, R. A. Wilson, R. M. Maizels, and J. E. Allen. 2005. Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect. Immun. 73: 385-394.
6. Bokarewa, M., I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski. 2005. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174: 5789-5795.
7. Silswal, N., A. K. Singh, B. Aruna, S. Mukhopadhyay, S. Ghosh, and N. Z. Ehtesham. 2005. Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-kB-dependent pathway. Biochem. Biophys. Res. Commun. 334: 1092-1101.
8. Steppan, C. M., E. J. Brown, C. M. Wright, S. Bhat, R. R. Banerjee, C. Y. Dai, G. H. Enders, D. G. Silberg, X.Wen, G. D.Wu, and M. A. Lazar. 2001. Afamily of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. USA 98: 502-506.
9. Liu, T., H. A. Baek, H. Yu, H. J. Lee, B. H. Park, M. Ullenbruch, J. Liu, T. Nakashima, Y. Y. Choi, G. D. Wu, et al. 2011. FIZZ2/RELM-b induction and role in pulmonary fibrosis. J. Immunol. 187: 450-461.
10. Nair, M. G., Y. Du, J. G. Perrigoue, C. Zaph, J. J. Taylor, M. Goldschmidt, G. P. Swain, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, et al. 2009. Alternatively activated macrophage-derived RELM-a is a negative regulator of type 2 inflammation in the lung. J. Exp. Med. 206: 937-952.
11. Herbert, D. R., J. Q. Yang, S. P. Hogan, K. Groschwitz, M. Khodoun, A. Munitz, T. Orekov, C. Perkins, Q. Wang, F. Brombacher, et al. 2009. Intestinal epithelial cell secretion of RELM-b protects against gastrointestinal worm infection. J. Exp. Med. 206: 2947-2957.
12. McVay, L. D., S. A. Keilbaugh, T. M.Wong, S. Kierstein, M. E. Shin, M. Lehrke, M. I. Lefterova, D. E. Shifflett, S. L. Barnes, F. Cominelli, et al. 2006. Absence of bacterially induced RELMb reduces injury in the dextran sodium sulfate model of colitis. J. Clin. Invest. 116: 2914-2923.
13. Hogan, S. P., L. Seidu, C. Blanchard, K. Groschwitz, A. Mishra, M. L. Karow, R. Ahrens, D. Artis, A. J. Murphy, D. M. Valenzuela, et al. 2006. Resistin-like molecule b regulates innate colonic function: barrier integrity and inflammation susceptibility. J. Allergy Clin. Immunol. 118: 257-268.
14. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2: 123-140.
15. World Gastroenterology Organisation. 2008. Acute Diarrhea. Available at: http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/ 01-acute-diarrhea.pdf
16. World Health Organization. 2009. Diarrhoea: Why Children Are Still Dying and What Can Be Done. Available at: http://www.who.int/maternal-child- adolescent/ documents/9789241598415/en/index.html
17. Sonnenberg, G. F., L. A. Monticelli, M. M. Elloso, L. A. Fouser, and D. Artis. 2011. CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122-134.
18. Ishigame, H., S. Kakuta, T. Nagai, M. Kadoki, A. Nambu, Y. Komiyama, N. Fujikado, Y. Tanahashi, A. Akitsu, H. Kotaki, et al. 2009. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108-119.
19. Vallance, B. A., W. Deng, L. A. Knodler, and B. B. Finlay. 2002. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect. Immun. 70: 2070-2081.
20. Geddes, K., S. J. Rubino, J. G. Magalhaes, C. Streutker, L. Le Bourhis, J. H. Cho, S. J. Robertson, C. J. Kim, R. Kaul, D. J. Philpott, and S. E. Girardin. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 17: 837-844.
21. Ivanov, I. I., K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
22. Mundy, R., T. T. MacDonald, G. Dougan, G. Frankel, and S. Wiles. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7: 1697-1706.
23. Kim, T. W., J. N. Seo, Y. H. Suh, H. J. Park, J. H. Kim, J. Y. Kim, and K. I. Oh. 2006. Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis. World J. Gastroenterol. 12: 302-305.
24. Taylor, B. C., C. Zaph, A. E. Troy, Y. Du, K. J. Guild, M. R. Comeau, and D. Artis. 2009. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J. Exp. Med. 206: 655-667.
25. Troy, A. E., C. Zaph, Y. Du, B. C. Taylor, K. J. Guild, C. A. Hunter, C. J. Saris, and D. Artis. 2009. IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. J. Immunol. 183: 2037-2044.
26. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
27. Priebe, G. P., R. L. Walsh, T. A. Cederroth, A. Kamei, Y. S. Coutinho-Sledge, J. B. Goldberg, and G. B. Pier. 2008. IL-17 is a critical component of vaccineinduced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. J. Immunol. 181: 4965-4975.
28. Wu, Q., R. J. Martin, J. G. Rino, R. Breed, R. M. Torres, and H. W. Chu. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 9: 78-86.
29. Huang, W., L. Na, P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190: 624-631.
30. Cook, P. C., L. H. Jones, S. J. Jenkins, T. A. Wynn, J. E. Allen, and A. S. MacDonald. 2012. Alternatively activated dendritic cells regulate CD4+ Tcell polarization in vitro and in vivo. Proc. Natl. Acad. Sci. USA 109: 9977-9982.
31. Kim, Y. G., N. Kamada, M. H. Shaw, N. Warner, G. Y. Chen, L. Franchi, and G. Núñez. 2011. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34: 769-780.
32. Pesce, J. T., T. R. Ramalingam, M. S. Wilson, M. M. Mentink-Kane, R. W. Thompson, A. W. Cheever, J. F. Urban, Jr., and T. A. Wynn. 2009. Retnla (relma/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog. 5: e1000393.
33. Shiomi, H., A. Masuda, S. Nishiumi, M. Nishida, T. Takagawa, Y. Shiomi, H. Kutsumi, R. S. Blumberg, T. Azuma, and M. Yoshida. 2010. Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection. Infect. Immun. 78: 2653-2666.
34. Teng, X., D. Li, H. C. Champion, and R. A. Johns. 2003. FIZZ1/RELMa, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ. Res. 92: 1065-1067.
35. Tong, Q., L. Zheng, Q. Kang, J. Dodd-O, J. Langer, B. Li, D. Wang, and D. Li. 2006. Upregulation of hypoxia-induced mitogenic factor in bacterial lipopolysaccharide-induced acute lung injury. FEBS Lett. 580: 2207-2215.
36. Loke, P., I. Gallagher, M. G. Nair, X. Zang, F. Brombacher, M. Mohrs, J. P. Allison, and J. E. Allen. 2007. Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J. Immunol. 179: 3926-3936.